BSE
EVERESTO

EVEREST ORGANICS LTD.

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

EVEREST ORGANICS LTD. Stock Price

Vitals

Today's Low:
₹121.05
Today's High:
₹131.8
Open Price:
₹125.9
52W Low:
₹95
52W High:
₹164.4522
Prev. Close:
₹125.9
Volume:
5468

Company Statistics

Market Cap.:
₹941.20 million
Book Value:
47.184
Revenue TTM:
₹1.71 billion
Operating Margin TTM:
10.11%
Gross Profit TTM:
₹659.54 million
Profit Margin:
6.59%
Return on Assets TTM:
8.9%
Return on Equity TTM:
0%

Company Profile

EVEREST ORGANICS LTD. had its IPO on under the ticker symbol EVERESTO.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. EVEREST ORGANICS LTD. has a staff strength of 407 employees.

Stock update

Shares of EVEREST ORGANICS LTD. opened at ₹125.9 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹121.05 - ₹131.8, and closed at ₹121.35.

This is a -3.61% slip from the previous day's closing price.

A total volume of 5,468 shares were traded at the close of the day’s session.

In the last one week, shares of EVEREST ORGANICS LTD. have increased by +6.08%.

EVEREST ORGANICS LTD.'s Key Ratios

EVEREST ORGANICS LTD. has a market cap of ₹941.20 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months EVEREST ORGANICS LTD.’s revenue was ₹1.71 billion with a gross profit of ₹659.54 million and an EBITDA of ₹205.42 million. The EBITDA ratio measures EVEREST ORGANICS LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, EVEREST ORGANICS LTD.’s operating margin was 10.11% while its return on assets stood at 8.9% with a return of equity of 0%.

In Q2, EVEREST ORGANICS LTD.’s quarterly earnings growth was a positive 10.4% while revenue growth was a positive 4.6%.

EVEREST ORGANICS LTD.’s PE and PEG Ratio

Forward PE
0
Trailing PE
8.379
PEG

Its diluted EPS in the last 12-months stands at ₹14.041 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into EVEREST ORGANICS LTD.’s profitability.

EVEREST ORGANICS LTD. stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

EVEREST ORGANICS LTD. stock pays annual dividends of ₹1 per share, indicating a yield of 0.85% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
₹0
Total Liabilities
₹762.31 million
Operating Cash Flow
₹0
Capital Expenditure
₹0
Dividend Payout Ratio
0%

EVEREST ORGANICS LTD. ended 2024 with ₹0 in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹0 while shareholder equity stood at ₹0.

EVEREST ORGANICS LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹762.31 million in other current liabilities, 80000000.00 in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

EVEREST ORGANICS LTD.’s total current assets stands at ₹848.95 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹494.93 million compared to accounts payable of ₹568.32 million and inventory worth ₹289.20 million.

In 2024, EVEREST ORGANICS LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, EVEREST ORGANICS LTD. paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price
₹121.35
52-Week High
₹164.4522
52-Week Low
₹95
Analyst Target Price

EVEREST ORGANICS LTD. stock is currently trading at ₹121.35 per share. It touched a 52-week high of ₹164.4522 and a 52-week low of ₹164.4522. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹121.36 and 200-day moving average was ₹111.57 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 7908.6% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About EVEREST ORGANICS LTD.

The stock symbol (also called stock or share ticker) of EVEREST ORGANICS LTD. is EVERESTO

The IPO of EVEREST ORGANICS LTD. took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
₹168.74
-3.58
-2.08%
₹28
0
0%
₹82.63
0.91
+1.11%
₹95.78
-0.12
-0.13%
₹715.4
-14.55
-1.99%
₹2.32
0
0%
₹26.22
0.06
+0.23%
BSL Limited (514045)
₹169
0.95
+0.57%
PEARL POLYMERS LTD. (PEARLPOLY)
₹26.72
-2.21
-7.64%
₹16.04
-0.4
-2.43%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
₹0.14
0.07
+100%
₹0.12
0.04
+45.29%
₹0.96
0.05
+5.4%
₹1.34
-0.35
-20.71%
Humbl Inc (HMBL)
₹0
0
0%

Top Gainers

Last Price
Chg
Chg%
₹0
0
+172200%
₹0
0
+51200%
₹283
280.03
+9428.62%
₹11.2
10.57
+1667.68%
Latch Inc (LTCHW)
₹0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
₹0.19
-123.15
-99.85%
₹0
-0.11
-99.55%
₹0
-0
-97.96%
₹0
-0.01
-93.94%
₹0.01
-0.06
-92.24%

About

Everest Organics Limited manufactures and sells active pharmaceutical ingredients and intermediaries. The company also manufactures bulk drugs. It exports bulk drugs, intermediates, drug formulations, biologicals, Ayush and herbal, and surgical products to the United States, Western Europe, Eastern Europe, South America, Egypt, Australia, Germany, Saudi Arabia, Dubai, China, Vietnam, Iran, Singapore, Indonesia, Bangladesh, Pakistan, Sri Lanka, and other Middle East countries. Everest Organics Limited was incorporated in 1993 and is based in Hyderabad, India.

Address

Lakeview Plaza, Hyderabad, India, 500033